Differentiation primary response genes and proto‐oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
By genetically manipulating hematopoietic cells of the myeloid lineage, including both normal cells and differentiation inducible leukemic cell lines, evidence was obtained to indicate that myeloid differentiation primary response (MyD) genes and proto-oncogenes, which are known to control cell growth, function as positive and negative regulators of terminal hematopoietic cell differentiation, which is associated with inhibition of cell growth, and, ultimately programmed cell death (apoptosis). Interferon regulatory factor-1 (IRF-1), an MyD gene induced by Interleukin 6 (IL-6) or Leukemia Inhibitory factor (LIF), plays a role in growth inhibition associated with terminal differentiation. Leucine zipper transcription factors of the fos/jun family, also identified as MyD genes, function as positive regulators of hematopoietic cell differentiation, increasing the propensity of myeloblastic leukemia cells to be induced for differentiation in vitro, and reducing the aggressiveness of their leukemic phenotype in vivo. The zinc finger transcription factor EGR-1, an MyD gene specifically induced upon macrophage differentiation, was shown to be essential for and to restrict differentiation along the macrophage lineage. Finally, evidence has been accumulating to indicate that the novel MyD genes—MyD116, MyD118 and gadd45 (a member in the MyD118 gene family)—play a role in growth arrest and apoptosis of hematopoietic cells, as well as other cell types. The proto-oncogenes c-myc and c-myb, known to regulate cellular growth, were shown to function as negative regulators of terminal differentiation. Both c-myc and c-myb are normally expressed in proliferating myeloblasts and suppressed following induction of differentiation. Deregulated and continuous expression of c-myc was shown to block terminal myeloid differentiation at an intermediate stage in the progression from immature blasts to mature macrophages, whereas deregulated and continuous expression of c-myb blocked the terminal differentiation program at the immature myeloblast stage. By manipulating myc function in conditional (differentiation inducible) mutant myeloblastic leukemia cell lines, expressing a chimeric mycer transgene, it was shown that there is a window during myeloid differentiation, after the addition of the differentiation inducer, when the terminal differentiation program switches from being dependent on c-myc suppression to becoming c-myc suppression independent, and where activation of c-myc has no apparent effect on mature macrophages. These myeloblastic leukemia cell lines provide a powerful tool to increase our understanding of the role of c-myc in normal hematopoiesis and in leukemogenesis, while also providing a strategy to clone myc target genes. The ongoing molecular-genetic dissection of terminal myeloid differentiation, growth arrest and apoptosis will continue to impart information on how these biological processes are normally controlled, as well as how a perturbation of these controls can play a role in leukemogenesis. Following through with this research, including the analysis of interactions between positive and negative differentiation regulators and their target genes, a regulatory network of molecular interactions should emerge, contributing to a greater understanding of the genetic events involved in the pathogenesis of different leukemias, ultimately aiding in diagnosis, prognosis and eventual therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metcalf, D. (1989) · Nature · doi:10.1038/339027a0 · Cited by 1,023
Lau, L. F., & Nathans, D. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1182 · Cited by 856
Prendergast, G. C., Lawe, D., & Ziff, E. B. (1991) · Cell · doi:10.1016/0092-8674(91)90457-a · Cited by 558
Nguyen, H. Q., Hoffman-Liebermann, B., & Liebermann, D. A. (1993) · Cell · doi:10.1016/0092-8674(93)90660-i · Cited by 367
Self-citationLord, K. A., Abdollahi, A., Hoffman-Liebermann, B., & Liebermann, D. A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.2.841-851.1993 · Cited by 54
Self-citation
Cited by
Repression of c- myc Transcription by Blimp-1, an Inducer of Terminal B Cell Differentiation
Lin, Y., Wong, K.-K., & Calame, K. (1997) · Science · doi:10.1126/science.276.5312.596 · Cited by 429
Quantitative production of macrophages or neutrophils ex vivo using conditional Hoxb8
Wang, G. G., Calvo, K. R., Pasillas, M. P., Sykes, D. B., Häcker, H., & Kamps, M. P. (2006) · Nature Methods · doi:10.1038/nmeth865 · Cited by 407
Transcriptional Repression by Blimp-1 (PRDI-BF1) Involves Recruitment of Histone Deacetylase
Yu, J., Angelin-Duclos, C., Greenwood, J., Liao, J., & Calame, K. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.7.2592-2603.2000 · Cited by 327
Lee, S. L., Wang, Y., & Milbrandt, J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4566 · Cited by 93
Transcription factors that regulate growth and differentiation of myeloid cells.
Nagamura-Inoue, T., Tamura, T., & Ozato, K. (2001) · International Reviews of Immunology · doi:10.3109/08830180109056724 · Cited by 94
Metadata
- Authors
- Liebermann, D. A., & Hoffman, B.
- Venue
- STEM CELLS
- Publisher
- Oxford University Press (OUP)
- Published
- 1994-01
- Volume
- 12
- Issue
- 4
- Pages
- 352-369
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W2089772658
- Cited by
- 56
- References
- 5
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Differentiation primary response genes and proto‐oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation. https://app.cochat.ai/papers/10.1002/stem.5530120402
- The paper
- Liebermann, D. A., & Hoffman, B. (1994). Differentiation primary response genes and proto‐oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation. STEM CELLS. https://doi.org/10.1002/stem.5530120402
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.